SlidesetHIVThe HIV Epidemic in Infants, Children, Adolescents and Women Today – 2021 UNAIDS Update - Mary Mahy, ScD, MHScView Slideset
SlidesetHIVPediatric HIV Treatment and Prevention: What’s New for 2021 - Martina Penazzato, MD, MSc, PhDView Slideset
SlidesetHIVLong-Acting HIV Prevention in Adolescents: Possibilities and Challenges - Mina Hosseinipour, MD, MPHView Slideset
SlidesetHIVApproaches to Enhance and Accelerate Study of New Drugs for HIV and Coinfections in Pregnancy - Shahin Lockman, MD, MScView Slideset
SlidesetHIVSituation Report: African COVID-19 Pandemic in Children - Shabir Madhi, MBBCh, FCPaeds, PhDView Slideset
SlidesetHIVProgress – and Lack of Progress - on DTG Transition in Children in Africa - Peter Elyanu, MBChB, M.Med, PhDView Slideset
SlidesetHIVOnce-Daily Integrase Inhibitor (Insti) With Boosted Darunavir is Non- Inferior to Standard of Care in Virogically Suppressed Children, Week 48 Results of the Smile PENTA-17 Trial - Alexandra Compagnucci, FranceView Slideset
SlidesetHIVB/F/Taf in Virologically Suppressed Adolescents and Children: Two- Year Outcomes in 6 to <18 Year Olds And Six-Month Outcomes in Toddlers - Eva Natukunda, UgandaView Slideset
SlidesetHIVPharmacokinetics and Safety of Dispersible- and Immediate-Release FDC Dolutegravir/Abacavir/Lamivudine in Children with HIV Weighing ≥14 Kg: Preliminary Results from IMPAACT 2019 - Kristina Brooks, United StatesView Slideset
SlidesetHIVClinical Impact and Cost-Effectiveness of Viral Load Testing (VLT) to Inform the Transition to Pediatric Dolutegravir (DTG) in Antiretroviral Therapy (ART)-Experienced Children With HIV in South Africa - Isaac Ravi Brenner, United StatesView Slideset
SlidesetHIVLATE BREAKER - Dolutegravir-Based Art is Superior to Standard of Care in Young Children Living With HIV - Pauline Amuge, UgandaView Slideset
SlidesetHIVPro (Children Should Be Prioritized) - Marieke van der Zalm, MD, MSc (Clin Epi), PhDView Slideset
SlidesetHIVWeight Gain in Children and Adolescents on Dolutegravir vs Standard-of-Care in the ODYSSEY Trial - Hilda Angela Mujuru, ZimbabweView Slideset
SlidesetHIVLongitudinal Study on Insulin Resistance and Metabolic Syndrome in Children with Perinatal HIV Infection and HIV Exposed Uninfected Children in South Africa - Claire Davies, South AfricaView Slideset
SlidesetHIVVirological Failures and Genotypic Resistance in Children and Adolescents Randomised to Dolutegravir-Based ART vs. Standard-of- Care in the ODYSSEY Trial - Cissy Kityo, UgandaView Slideset
SlidesetHIVHypertensive Disorders in Pregnancy and HIV: A Province-Wide Cohort Analysis During 2018 and 2019 in the Western Cape, South Africa - Amy Slogrove, South AfricaView Slideset
SlidesetHIVBone Mineral Density/Content of Postpartum Mothers Taking Treatment Including DTG Vs EFV, TDF Vs TAF in Pregnancy and Their Infants: Randomized IMPAACT 2010 Trial - Tapiwa Mbengeranwa, ZimbabweView Slideset
SlidesetHIVImpact of the COVID-19 Pandemic on Perinatal HIV Prevention in Canada: Canadian Perinatal HIV Surveillance Program - Joel Singer, CanadaView Slideset
SlidesetHIVEarly Infant Diagnosis of HIV and Linkage to Antiretroviral Therapy in the Context of COVID-19 in Fifteen Sub-Saharan African Countries - Elizabeth Rabold, United StatesView Slideset
SlidesetHIVThe Impact of COVID-19 on HIV Services for Children Living with HIV Across 14 Countries - Megan Gleason, United StatesView Slideset
SlidesetHIVPediatric and Adolescent HIV Viral Load Coverage and Suppression Rates in the Context of the COVID-19 Pandemic in 14 Sub-Saharan African PEPFAR Countries in 2019 and 2020 - Deborah Carpenter, United StatesView Slideset
SlidesetHIVKnowledge and Perceptions of Covid-19 Among Young People Living With HIV in Malawi and the Impact of the Pandemic on Their Health and Wellbeing - Kajal Hirani, MalawiView Slideset
SlidesetHIVMore Frequent Viral Load Testing, With Point-Of-Care Tests Has No Impact on Viral Suppression in Postpartum HIV-Positive Women in a Randomized Controlled Trial in 2 Clinics in Johannesburg, South Africa - Lee Fairlie, South AfricaView Slideset
SlidesetHIVUsability and Feasibility of an HIV POC Viral Load to Identify Infants at High Risk of MTCT at Birth in Primary Healthcare Clinics in Mozambique - Bindiya Meggi, MozambiqueView Slideset
SlidesetHIVKey Clinical and Programmatic Outcomes of HIV-Exposed Infants in the International Epidemiology Databases to Evaluate AIDS Consortium - Andrew Edmonds, United StatesView Slideset
SlidesetHIVDeterminants of HIV-Free Survival in the Era of Lifelong Universal Antiretroviral Therapy (ART): Pooled Analysis of PEAWIL and IMPROVE Studies, Lesotho - Appolinaire Tiam, United StatesView Slideset
SlidesetHIVIncreased Infectious-Cause Hospitalization Among Infants Who Are HIV-Exposed Uninfected Compared to HIV-Unexposed - Kim Anderson, South AfricaView Slideset
SlidesetHIVGrowth of Children HIV-Exposed and Uninfected in The Context of Lifelong Maternal Antiretroviral Therapy in Malawi - Gabriela Toledo, United KingdomView Slideset
SlidesetHIVThere is No Substitute for Hard Work(Ing Dolutegravir): Outcomes of Single Drug Substitutions Among CALHIV Shifted to a Dolutegravir Antiretroviral Regimen in Mbeya and Mwanza, Tanzania - Jason Bacha, TanzaniaView Slideset
SlidesetHIVPediatric ARV Optimization in a Real-World Setting: Dolutegravir Transition in Mozambique - Michelle M. Gill, United StatesView Slideset
SlidesetHIVCo-Trimoxazole Prophylaxis for Children Born to Mothers With HIV: Predicted Impact of Different Strategies on Mortality Up To the Age of Two Years - Colette Smith, United KingdomView Slideset
SlidesetHIVRisk Factors for Post-Discharge Mortality Following Hospitalization for Severe Acute Malnutrition in Zimbabwe and Zambia - Mutsa Bwakura-Dangarembizi, ZimbabweView Slideset
SlidesetHIVEstimated Prevalence of Prior HIV Diagnosis Among Children Living With HIV in Eswatini, Lesotho, Malawi, Tanzania, Zambia, and Zimbabwe in the Population HIV Incidence Assessments (PHIA) - Chloe A. Teasdale, United StatesView Slideset
SlidesetHIVA Costing Analysis of Index-Linked HIV Testing for Children and Adolescents in Zimbabwe - Arthi Vasantharoopan, United KingdomView Slideset
SlidesetHIVRapid Antiretroviral NNRTI-Based Initiation among Youth Living with HIV Outcomes in the National Aids Program in Thailand - Sirinya Teeraananchai, ThailandView Slideset
SlidesetHIVOptimizing Antiretroviral Treatment and Viral Suppression for Adolescents and Young People Living with HIV by Implementing Operation Triple Zero (OTZ) in Four States in Nigeria - Franklin Emerenini, NigeriaView Slideset
SlidesetHIVProjecting Life Expectancy for Youth with Non-Perinatally- and Perinatally-Acquired HIV in the United States - Anne Neilan, United StatesView Slideset
SlidesetHIVHospitalisation Rates for Youth Living with Perinatally acquired HIV Transitioning to Adult Care - Sarah Johnson, United KingdomView Slideset
SlidesetHIVIncreasing Capacity to Detect Neurocognitive Impairment among Adolescents and Young Adults with Perinatally Acquired HIV in Thailand: Validity of the NeuorScreen Tablet Application - Reuben N. Robbins, United StatesView Slideset
SlidesetHIVDevelopment of a Transition Readiness Score for Adolescents Living with Perinatally-Acquired HIV and Transitioning to Adult Care - Brian Zanoni, United StatesView Slideset
SlidesetHIVCon (Children Should Not Be Prioritized) - Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVSView Slideset
